AME.NYSEAmetek Inc/

Form 4: AMETEK Executive Sells Shares After Option Exercise

Sentiment:

Insider Transaction Report


AMETEK's President of Electronic Instruments, Thomas C. Marecic, exercised stock options and subsequently sold 14,310 shares of common stock.

Summary

  • Thomas C. Marecic, President of Electronic Instruments at AMETEK INC/, reported transactions on December 15, 2025.
  • Marecic acquired 14,310 shares of Common Stock by exercising stock options at a price of $63.37 per share.
  • Concurrently, Marecic disposed of 14,310 shares of Common Stock at an average price of $202.1131 per share, with sales ranging from $202.00 to $202.44.
  • Following these transactions, Marecic directly beneficially owns 42,589 shares of Common Stock and 13,553 shares of Common Stock/Serp.
  • Indirect beneficial ownership includes 3,029 shares in a 401k Plan and 348 shares held by his wife.
  • The exercised stock options had an exercise price of $63.37 and an expiration date of March 20, 2030, with exercisability in three equal annual installments beginning March 20, 2021.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving the exercise of stock options and subsequent sale of shares, which is generally considered neutral. The executive realized a profit, indicating past stock appreciation, but the sale itself is a common personal financial event.

Positives

  • The executive realized a significant profit from exercising options and selling shares, indicating the stock's appreciation since the options were granted (exercise price $63.37 vs. sale price ~$202.11).

Negatives

  • An insider selling shares, even after an option exercise, can sometimes be perceived negatively by the market, though it is often for personal financial planning and diversification.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This is a routine insider transaction report and does not provide information directly related to broader industry trends or competitive landscape.

Stakeholder Impact

  • Shareholders: The transaction is a routine insider sale following option exercise, which typically has minimal direct impact on other shareholders. It demonstrates an executive monetizing vested equity.

Key Dates

DateDescription
03/20/2021Start date for stock option exercisability in three equal annual installments.
12/15/2025Date of stock option exercise and subsequent sale of common stock.
03/20/2030Expiration date of the exercised stock options.

Keywords

AMETEK, AME, Form 4, Insider Trading, Stock Option Exercise, Share Sale, Beneficial Ownership, Thomas C. Marecic, Electronic Instruments

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.